Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SiderAL Folico is a dietary supplement formulated to address iron deficiency and support increased nutritional needs, particularly in women during menstruation, pregnancy, postpartum periods, and old age. It contains sucrosomial iron (a patented form of ferric pyrophosphate encapsulated in a phospholipid-sucrose ester matrix for enhanced absorption), folic acid (vitamin B9), vitamin C (ascorbic acid), vitamin D3 (cholecalciferol), vitamin B6 (pyridoxine hydrochloride), and vitamin B12 (cyanocobalamin). The sucrosomial technology allows the iron to bypass the stomach with minimal gastrointestinal side effects and improved bioavailability compared to traditional oral iron supplements. The combination of these nutrients supports normal red blood cell formation, hemoglobin synthesis, immune function, energy metabolism, cognitive function, reduction of tiredness/fatigue, maternal tissue growth during pregnancy, and bone health. It is gluten- and lactose-free and designed as an orosoluble powder that dissolves directly in the mouth without water[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SiderAL Folico.